NorthWest Biotherapeutics Inc (NWBO)

[AllSheWrote]

“recurring operating losses” this is normal for al pre revenue biotechs - nothing abnormal or surprising here.

I am so sick of this pathetic argument - straight from the bioharm playbook. At what point does it become abnormal? Five years? Ten years? Or, in the case of this company, 25 years? You can use the pre-revenue excuse for only so long. Eventually a public company must produce shareholder return. If a public company has not produced any shareholder return after 25 years, then something is seriously wrong. The fact that shareholders like you don't seem to care only compounds the problem.